The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
XRCC1 mutation is associated with PARP1 hyperactivation and cerebellar ataxia
Open accessAbstract
XRCC1 is a molecular scaffold protein that assembles multi-protein complexes involved in DNA single-strand break repair. Here we show that biallelic mutations in the human XRCC1 gene are associated with ocular motor apraxia, axonal neuropathy, and progressive cerebellar ataxia. Cells from a patient with mutations in XRCC1 exhibited not only reduced rates of single-strand break repair but also elevated levels of protein ADP-ribosylation. This latter phenotype is recapitulated in a related syndrome caused by mutations in the XRCC1 partner protein PNKP and implicates hyperactivation of poly(ADP-ribose) polymerase/s as a cause of cerebellar ataxia. Indeed, remarkably, genetic deletion of Parp1 rescued normal cerebellar ADP-ribose levels and reduced the loss of cerebellar neurons and ataxia in Xrcc1-defective mice, identifying a molecular mechanism by which endogenous single-strand breaks trigger neuropathology. Collectively, these data establish the importance of XRCC1 protein complexes for normal neurological function and identify PARP1 as a therapeutic target in DNA strand break repair-defective disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“High levels of nuclear DNA damage, e.g. in cells from aged organisms or DNA repair mutants, lead to prolonged activation of PARP1, a DNA break sensor that upon activation consumes large amounts of NAD+60.”
From The central role of DNA damage in the ageing process (2021) · cites this paper as [60]
In the citing paper
“With the exception of AOA5, which seems to have manifested exclusively in adults so far (Hoch et al, 2017: 1; O’Connor et al, 2018: 1), the majority of DNA damage disorders typically present in early childhood.”
From Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease (2022) · cites this paper as Hoch et al, 2017: 1
In the citing paper
“Defective XRCC1 manifests in individuals as Ataxia with Oculomotor apraxia Type 5 (AOA5), another slow‐progressing neurodegenerative disease.”
From Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease (2022) · cites this paper as Hoch et al, 2017
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Improving CRISPR-Cas nuclease specificity using truncated guide RNAs
Fu, Y., Sander, J. D., Reyon, D., Cascio, V. M., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2808 · Cited by 1,993
Single-strand break repair and genetic disease
Caldecott, K. W. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2380 · Cited by 1,097
Self-citationPoly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia
Eliasson, M. J. L., Sampei, K., Mandir, A. S., Hurn, P. D., Traystman, R. J., Bao, J., Pieper, A. A., Wang, Z., Dawson, T. M., Snyder, S. H., et al. (1997) · Nature Medicine · doi:10.1038/nm1097-1089 · Cited by 1,019
Self-citationMice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease.Preprint
Wang, Z. Q., Auer, B., Stingl, L., Berghammer, H., Haidacher, D., Schweiger, M. R., & Wagner, E. F. (1995) · Genes & Development · doi:10.1101/gad.9.5.509 · Cited by 774
Self-citationXRCC1 and DNA strand break repair
Caldecott, K. W. (2003) · DNA repair · doi:10.1016/s1568-7864(03)00118-6 · Cited by 609
Self-citationBradley, M. O., & Kohn, K. W. (1979) · Nucleic Acids Research · doi:10.1093/nar/7.3.793 · Cited by 565
Takashima, H., Boerkoel, C. F., John, J., Saifi, G. M., Salih, M. A. M., Armstrong, D., Mao, Y., Quiocho, F. A., Roa, B. B., Nakagawa, M., et al. (2002) · Nature Genetics · doi:10.1038/ng987 · Cited by 522
The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn-finger protein aprataxin
Moreira, M.-C., Barbot, C., Tachi, N., Kozuka, N., Uchida, E., Gibson, T. J., Mendonça, P., Costa, M. M. R., Barros, J., Yanagisawa, T., et al. (2001) · Nature Genetics · doi:10.1038/ng1001-189 · Cited by 434
Defective DNA single-strand break repair in spinocerebellar ataxia with axonal neuropathy-1
El‐Khamisy, S. F., Saifi, G. M., Weinfeld, M., Johansson, F., Helleday, T., Lupski, J. R., & Caldecott, K. W. (2005) · Nature · doi:10.1038/nature03314 · Cited by 428
Self-citationRequirement for theXrcc1DNA Base Excision Repair Gene during Early Mouse Development
Tebbs, R. S., Flannery, M. L., Meneses, J. J., Hartmann, A., Tucker, J. D., Thompson, L. H., Cleaver, J. E., & Pedersen, R. A. (1999) · Developmental Biology · doi:10.1006/dbio.1999.9232 · Cited by 344
Involvement of XRCC1 and DNA Ligase III Gene Products in DNA Base Excision Repair
Cappelli, E., Taylor, R., Cevasco, M., Abbondandolo, A., Caldecott, K. W., & Fròsina, G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.38.23970 · Cited by 341
Self-citationPoly(ADP-ribose) polymerase: killer or conspirator? The ‘suicide hypothesis’ revisited
Chiarugi, A. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01902-7 · Cited by 298
Mutations in PNKP cause microcephaly, seizures and defects in DNA repair
Shen, J., Gilmore, E. C., Marshall-Walker, C. A., Haddadin, M. H., Reynolds, J. J., Eyaid, W., Bodell, A., Barry, B. J., Gleason, D., Allen, K., et al. (2010) · Nature Genetics · doi:10.1038/ng.526 · Cited by 294
Self-citationCaldecott, K. W., Tucker, J. D., Lh, S., & Thompson, L. H. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.23.4836 · Cited by 291
Self-citationMarras, C., Lang, A. E., van de Warrenburg, B. P. C., Sue, C. M., Tabrizi, S. J., Bertram, L., Mercimek‐Andrews, S., Ebrahimi‐Fakhari, D., Warner, T. T., Dürr, A., et al. (2016) · Movement Disorders · doi:10.1002/mds.26527 · Cited by 285
Katyal, S., Lee, Y., Nitiss, K. C., Downing, S. M., Li, Y., Shimada, M., Zhao, J., Russell, H. R., Petrini, J. H. J., Nitiss, J. L., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3715 · Cited by 152
Self-citationMutations in PNKP Cause Recessive Ataxia with Oculomotor Apraxia Type 4
Brás, J., Alonso, I. D. C. M. P., Barbot, C., Costa, M. M., Darwent, L., Orme, T., Sequeiros, J., Hardy, J., Coutinho, P., & Guerreiro, R. J. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.01.005 · Cited by 133
The genesis of cerebellar interneurons and the prevention of neural DNA damage require XRCC1
Lee, Y., Katyal, S., Li, Y., El‐Khamisy, S. F., Russell, H. R., Caldecott, K. W., & McKinnon, P. J. (2009) · Nature Neuroscience · doi:10.1038/nn.2375 · Cited by 115
Self-citationProgressive cerebellar atrophy and polyneuropathy: expanding the spectrum of PNKP mutations
Poulton, C. J., Oegema, R., Heijsman, D., Hoogeboom, J. A. M., Schot, R., Stroink, H., Willemsen, M. A. A. P., Verheijen, F. W., van der Spek, P. J., Kremer, A., et al. (2012) · Neurogenetics · doi:10.1007/s10048-012-0351-8 · Cited by 73
Self-citationPinkel, D., Thompson, L. H., Gray, J. W., & Vanderlaan, M. (1985) · PubMed · Cited by 68
Breslin, C., & Caldecott, K. W. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00677-09 · Cited by 63
Self-citationRescue of Xrcc1 knockout mouse embryo lethality by transgene-complementation
Tebbs, R. S., Thompson, L. H., & Cleaver, J. E. (2003) · DNA repair · doi:10.1016/j.dnarep.2003.08.007 · Cited by 63
Dillehay, L. E., Thompson, L. H., Minkler, J. L., & Carrano, A. V. (1983) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(83)90053-2 · Cited by 60
Whole-exome sequencing identifies novel ECHS1 mutations in Leigh syndrome
Tétreault, M., Fahiminiya, S., Antonická, H., Mitchell, G. A., Geraghty, M. T., Lines, M. A., Boycott, K. M., Shoubridge, E. A., Mitchell, J. J., Michaud, J. L., et al. (2015) · Human Genetics · doi:10.1007/s00439-015-1577-y · Cited by 54
Self-citationMeasurement of Chromosomal DNA Single‐Strand Breaks and Replication Fork Progression Rates
Breslin, C., Clements, P. M., El‐Khamisy, S. F., Petermann, E., Iles, N., & Caldecott, K. W. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)09024-5 · Cited by 49
Self-citation
Cited by
Sorted by citations
The multifaceted roles of PARP1 in DNA repair and chromatin remodelling
Ray Chaudhuri, A., & Nussenzweig, A. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.53 · Cited by 1,786
The central role of DNA damage in the ageing process
Schumacher, B., Pothof, J., Vijg, J., & Hoeijmakers, J. H. J. (2021) · Nature · doi:10.1038/s41586-021-03307-7 · Cited by 907
DNA damage responses and p53 in the aging process
Ou, H.-L., & Schumacher, B. (2018) · Blood · doi:10.1182/blood-2017-07-746396 · Cited by 377
Hanzlíková, H., Kalasová, I., Demin, A. A., Pennicott, L. E., Cihlářová, Z., & Caldecott, K. W. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.06.004 · Cited by 407
Self-citationCellular functions of the protein kinase ATM and their relevance to human disease
Lee, J., & Paull, T. T. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00394-2 · Cited by 303
Metadata
- Authors
- Care4Rare Canada Consortium, Hoch, N. C., Hanzlikova, H., Rulten, S. L., Tétreault, M., Komulainen, E., Ju, L., Hornyak, P., Zeng, Z., Gittens, W., Rey, S. A., Staras, K., Mancini, G. M. S., McKinnon, P. J., Wang, Z.-Q., Wagner, J. D., Yoon, G., & Caldecott, K. W.
- Affiliations
- University of Sussex (GB)
- McGill University and Génome Québec Innovation Centre (CA)
- Erasmus MC (NL)
- St. Jude Children's Research Hospital (US)
- Leibniz Institute on Aging - Fritz Lipmann Institute (FLI) (DE)
- Children's Hospital of Eastern Ontario (CA)
- University of Toronto (CA)
- Corresponding author
- Yoon, Grace
- Caldecott, Keith W.
- ORCID
- Venue
- Nature
- Published
- 2016-12-21
- Volume
- 541
- Issue
- 7635
- Pages
- 87-91
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC5218588
- OpenAlex
- W2563186352
- Cited by
- 269
- References
- 26
- Citations by year
- 2026: 18 · 2025: 22 · 2024: 23 · 2023: 17 · 2022: 33 · 2021: 35 · 2020: 36 · 2019: 30 · 2018: 32 · 2017: 22 · 2016: 1
- FWCI
- 14.73
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Sussex Research Online (University of Sussex) (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- RePEc: Research Papers in Economics (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- Cancer Research UK (16771)
- Medical Research Council (MR/J006750/1, MR/P010121/1)
- Biotechnology and Biological Sciences Research Council (BB/K019015/1)
- National Cancer Institute (P01CA096832, P30CA021765)
- National Institute of Neurological Disorders and Stroke (R56NS037956, R01NS037956)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Keywords
- XRCC1, PARP1, cerebellar ataxia, ocular motor apraxia, axonal neuropathy, DNA single-strand break repair, ADP-ribosylation, ADP-ribose, PNKP, therapeutic target
- MeSH terms
- Poly (ADP-Ribose) Polymerase-1, X-ray Repair Cross Complementing Protein 1, Adenosine Diphosphate Ribose, Alleles, Animals, Apraxias, Ataxia, Axons, Cerebellar Ataxia, Cerebellum, Chromatin, DNA Repair, DNA-Binding Proteins, Female, Humans, Interneurons, Male, Mutation, Pedigree, Phenotype, Phosphotransferases (Alcohol Group Acceptor), DNA Repair Enzymes, Mice, DNA Breaks, Single-Stranded, Cogan Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
